Jerzy S.
- Country
- Poland
- Department
- NA
Research Overview
- Efficacy and Safety of Zenagamtide in Participants with Overweight or Obesity and Knee Osteoarthritis
- Efficacy and Safety of Zenagamtide (NNC0487-0111) in Participants with Overweight or Obesity and Knee Osteoarthritis
- Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of BP16 Compared to Denosumab in Post-Menopausal Osteoporosis Patients
Data & Insights
Has run more than one trial at 39 of 175 partner sites.
Specializations
Bone Health and Metabolic Disorders
The investigator specializes in treating conditions affecting bone density and metabolism, with particular focus on postmenopausal osteoporosis and its management through innovative therapeutic approaches.
- Bone mineral density assessment
- Metabolic bone markers evaluation
- Osteoporosis treatment
Research involves assessment of bone density markers and comparative therapeutic interventions for osteoporosis management.
Rheumatic Conditions
Expertise extends to chronic inflammatory conditions, including axial spondyloarthritis and osteoarthritis, with emphasis on pain management and disease progression control.
- Chronic knee osteoarthritis
- Non-radiographic axial spondyloarthritis
- Pain management protocols
Focus includes evaluation of therapeutic interventions for chronic pain relief and inflammation control.
Autoimmune Disorders
Investigates treatment approaches for various autoimmune conditions, including psoriatic arthritis, juvenile idiopathic arthritis, and chronic plaque psoriasis.
- Inflammatory arthritis management
- Long-term disease control
- Treatment maintenance strategies
Specializes in evaluating long-term therapeutic outcomes and maintenance treatments for autoimmune conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
